Mad Money

Cramer's lightning round: Hold Doximity for the long run

Key Points
  • It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

Doximity: "Doximity is, it's such a great company, up very big today. Here's the problem with Doximity, that's the kind of stock that people have turned on. ... I think you hold Doximity for the long run. That's how you make money."

Abbott Laboratories: "That's the reason why people have been shying away from buying the stock, but they sure aren't shying away from buying [rapid Covid test] BinaxNOW. I think that this thing is going to be with us for a long time. Remember, they already preannounced bad for BinaxNOW. They're not preannouncing good, but Abbott's got so many other things going for it. Let's not call it a BinaxNOW story. I like Abbott, but I've liked it for multiple years and will continue to do so for the charitable trust and, of course, the CNBC Investing Club."

Tilray: "Look, Irwin Simon runs it, used to run Hain. I happen to like him very much. I don't like the cannabis industry except for the industrial real estate part, which is a REIT. The cannabis industry has just caused a lot of heartache, and between SPACs and cannabis, there are a lot of people who have left our stock market. I don't want that to happen to you."

Upwork: "Upwork, I mean, it's like Indeed. These are like recruitment companies that are very important right now. They do it for high and white-collar people. The stock has had its high, but I think it can go higher. It's not a bad company."

Disclosure: Cramer's charitable trust owns shares of Abbott Labs.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com